Target Name: NFRKB
NCBI ID: G4798
Review Report on NFRKB Target / Biomarker Content of Review Report on NFRKB Target / Biomarker
NFRKB
Other Name(s): Nuclear factor related to kappa-B-binding protein | Nuclear factor related to kappaB binding protein, transcript variant 1 | Nuclear factor related to kappaB binding protein, transcript variant 2 | DNA-binding protein R kappa B | DKFZp547B2013 | Nuclear factor related to kappa-B-binding protein (isoform 1) | nuclear factor related to kappaB binding protein | DNA-binding protein R kappa-B | INO80G | NFRKB variant 1 | INO80 complex subunit G | NFRKB variant 2 | NFRKB_HUMAN | Nuclear factor related to kappa-B-binding protein (isoform 2)

NF-kappa-B: Regulating Inflammation and Pain Perception

Nuclear factor-related to kappa-B-binding protein (NF-kappa-B) is a protein that plays a crucial role in cellular signaling. It is a protein that is highly expressed in various tissues and cells, including the brain, and is involved in various physiological processes, including inflammation, cell growth, and differentiation.

One of the functions of NF-kappa-B is to regulate the activity of other proteins that are involved in signaling pathways. These proteins include nuclear factor-related to p21 (NF-p21), which is a transcription factor that is involved in the regulation of cell growth and apoptosis. Another protein that is highly expressed in NF-kappa-B-positive cells is the transcription factor-related to DNA binding protein, called p65.

NF-kappa-B is also involved in the regulation of inflammation. It is a well-known fact that NF-kappa-B is involved in the regulation of various types of inflammation, including both acute and chronic inflammation. the production of pro-inflammatory cytokines, such as TNF-alpha, IL-1, and IL-6.

One of the ways that NF-kappa-B is involved in inflammation is through its ability to activate the transcription factor-related to gene expression (NF-GRE), which is a protein that is involved in the regulation of gene expression. NF-GRE is able to bind to specific DNA sequences and regulate the activity of the transcription factors that are involved in gene expression. This is important because NF-GRE is able to control the production of pro-inflammatory cytokines, which can contribute to the development of various types of inflammation.

Another way that NF-kappa-B is involved in inflammation is through its role in the regulation of pain perception. NF-kappa-B is involved in the production of pro-inflammatory cytokines, such as TNF-alpha, which is known to contribute to pain perception. Additionally, NF-kappa-B is also involved in the regulation of the production of neurotransmitters, such as serotonin and dopamine, which can also contribute to pain perception.

In conclusion, NF-kappa-B is a protein that is involved in a variety of cellular processes, including inflammation, cell growth, and differentiation. Its role in these processes makes it an attractive target for drug development. The use of small molecules, such as inhibitors of NF-GRE, have been shown to be effective in reducing inflammation and the symptoms associated with pain perception. Further research is needed to fully understand the role of NF-kappa-B in cellular processes and to develop effective treatments.

Protein Name: Nuclear Factor Related To KappaB Binding Protein

Functions: Binds to the DNA consensus sequence 5'-GGGGAATCTCC-3'

The "NFRKB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NFRKB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NFS1 | NFU1 | NFX1 | NFXL1 | NFYA | NFYAP1 | NFYB | NFYC | NFYC-AS1 | NFYCP2 | NGB | NGDN | NGEF | NGF | NGFR | NGFR-AS1 | NGLY1 | NGRN | NHEG1 | NHEJ1 | NHERF1 | NHERF2 | NHERF4 | NHLH1 | NHLH2 | NHLRC1 | NHLRC2 | NHLRC3 | NHLRC4 | NHP2 | NHP2P1 | NHS | NHSL1 | NHSL1-AS1 | NHSL2 | NIBAN1 | NIBAN2 | NIBAN3 | Nicalin-NOMO complex | NICN1 | Nicotinic (alpha4beta2)2alpha4 receptor | Nicotinic (alpha4beta2)2beta2 receptor | Nicotinic alpha1beta1deltaepsilon Receptor | Nicotinic alpha1beta1deltagamma Receptor | Nicotinic alpha3alpha6beta2 Receptor | Nicotinic alpha3beta2 receptor | Nicotinic alpha3beta2beta3 receptor | Nicotinic alpha3beta4 Receptor | Nicotinic alpha4beta2 receptor | Nicotinic alpha4beta2alpha5 Receptor | Nicotinic alpha4beta4 receptor | Nicotinic alpha6alpha3beta2 Receptor | Nicotinic alpha6alpha3beta2beta3 receptor | Nicotinic alpha6beta2alpha4beta2beta3 receptor | Nicotinic alpha6beta2beta3 receptor | Nicotinic alpha6beta4beta3alpha5 receptor | Nicotinic alpha9alpha10 Receptor | NID1 | NID2 | NIF3L1 | NIFK | NIFK-AS1 | NIHCOLE | NIM1K | NIN | NINJ1 | NINJ2 | NINJ2-AS1 | NINL | NIP7 | NIPA1 | NIPA2 | NIPAL1 | NIPAL2 | NIPAL3 | NIPAL4 | NIPBL | NIPBL-DT | NIPSNAP1 | NIPSNAP2 | NIPSNAP3A | NIPSNAP3B | NISCH | NIT1 | NIT2 | Nitric oxide synthase (NOS) | NKAIN1 | NKAIN1P1 | NKAIN2 | NKAIN3 | NKAIN4 | NKAP | NKAPD1 | NKAPL | NKAPP1 | NKD1 | NKD2 | NKG7 | NKILA | NKIRAS1